Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-009888

Chief Medical Officer sold 1,470 shares at an average $74.68 ($109,785)

  • Chief Medical Officer acquired 4,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2021-02-07 Option exercise +4,250 169,391 I
Ho Carole Chief Medical Officer 2021-02-09 Sale −1,006 $74.40 $74,847 168,385 I
Ho Carole Chief Medical Officer 2021-02-09 Sale −364 $75.10 $27,337 168,021 I
Ho Carole Chief Medical Officer 2021-02-09 Sale −100 $76.00 $7,600 167,921 I
Derivatives
Ho Carole Chief Medical Officer 2021-02-07 Option exercise · Restricted Stock Units −4,250 8,500 D
Open-market sales · 1,470 sh · avg $74.68 · $109,785
Loading xslF345X03/doc4.xml…